The vaccine development process and coordination between health organizations have improved since a devastating 2014-2016 ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Vaccinations have revolutionized healthcare, but designing them remains complex, requiring time and creativity, especially for vaccines against viruses, which are difficult to study. “Each virus ...

Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans for the first time, finding it to ...

The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each year. In Romania, the prevalence of both diseases is notably high ...

Vaccines are the most efficacious means of minimizing the impact of infectious diseases on the human population. The challenges and importance of making vaccines that will meet FDA approval have never ...

Vaccine development for aquaculture species encompasses a diverse array of approaches designed to prevent bacterial, viral and parasitic diseases in farmed fish. Conventional strategies include ...

The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and ...

The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services French Ministry approval recognizes Intravacc as a private ...